Doctors Note Logo

Published on: 10/14/2026

Follistatin 344: what it claims and what is proven

Follistatin 344 is marketed as a myostatin-blocking peptide said to build muscle, reduce fat, and aid recovery, but these claims rest almost entirely on animal gene-therapy studies and have not been proven safe or effective in humans. It is not FDA-approved for any use, is sold only as a research chemical, and unregulated products carry risks of contamination, dosing errors, unknown effects on tissue growth, and banned-substance violations in sport. Several important distinctions separate the lab evidence from the marketing, and they are detailed below before considering any use.

If you are weighing a peptide like this because of fatigue, muscle loss, slow recovery, or unexplained body composition changes, those symptoms often have treatable medical causes worth identifying first. Take a free, instant, online symptom check to see what may be driving how you feel and get clear guidance on your next steps.

Last reviewed for medical accuracy: 10/13/2026

answer background

Concerned about your symptoms?

Explanation

What Is Follistatin 344?
Follistatin 344 is a naturally occurring protein precursor made up of 344 amino acids. It belongs to the follistatin family, which binds and neutralizes activins—molecules that regulate muscle growth, inflammation, and hormone release. In the body, the signal peptide is removed, producing shorter, active forms (commonly Follistatin 288 and Follistatin 315). Researchers often refer to the full-length precursor as “follistatin 344” when discussing gene therapy or laboratory studies.

How Follistatin 344 Works

  • Binds to activin A and other TGF-β family members, blocking their ability to limit muscle cell growth.
  • Encourages muscle cells (myoblasts) to fuse and enlarge, supporting increased muscle mass in animal models.
  • May influence reproductive hormones by modulating activin’s role in follicle-stimulating hormone (FSH) release.

Common Claims Around Follistatin 344
Enthusiasts and supplement marketers often assert that follistatin 344 can:

  • Dramatically boost muscle growth and strength
  • Accelerate fat loss or improve body composition
  • Enhance athletic performance and recovery
  • Support anti-aging by preserving muscle and reducing inflammation
  • Influence fertility or hormone balance

What Science Has Actually Proven
While the theoretical benefits are attractive, solid human data are very limited. Here’s what credible research shows so far:

Animal Studies

  • Mice engineered to overexpress follistatin (via genetic manipulation) develop larger muscles and show improved strength without obvious health issues (Amthor et al., 2004; McPherron & Lee, 1997).
  • Non-human primates receiving adeno-associated viral (AAV) vectors carrying the human FST344 gene gained lean muscle mass and exhibited greater grip strength over 12 weeks, with no immediate toxicity reported (Yoshida et al., 2013).

Early-Phase Human Trials

  • A small intramuscular gene therapy trial injected AAV1-FST344 into a few adult males with Becker muscular dystrophy. Results showed local increases in follistatin levels and modest myofiber enlargement. No serious adverse events were noted in the short term (Mendell et al., 2009).
  • Systemic delivery of AAV-FST344 in humans remains experimental and is not approved by any major regulatory agency.

Key Takeaways from Research

  • Follistatin 344 can increase muscle size in animals.
  • Early human data are confined to targeted gene therapy in rare muscle-wasting disorders.
  • There is no robust, peer-reviewed evidence supporting follistatin 344 for general fitness, bodybuilding, or anti-aging in healthy individuals.

Safety and Unanswered Questions

  • Long-term effects of increasing follistatin levels systemically are unknown.
  • Potential risks include unintended immune reactions to viral vectors or the protein itself.
  • Off-target effects on reproductive hormones, organ systems, or cancer risk have not been fully explored.
  • Since follistatin also affects cell growth, there is theoretical concern about promoting abnormal tissue proliferation.

Regulatory Status

  • Follistatin 344 is not approved as a drug, supplement, or therapy by the FDA, EMA, or other major health authorities.
  • Any products or clinics offering follistatin 344 injections or gene therapy are operating in an unregulated space.

Should You Consider Follistatin 344?
Given the current evidence:

  • If you have a serious muscle-wasting disease, enrolling in a registered clinical trial under expert care may be an option.
  • For general muscle building or fat loss, proven strategies (resistance training, balanced nutrition, adequate sleep) remain far safer and better studied.
  • Always approach novel therapies with caution, especially those lacking long-term safety data.

If you’re experiencing unexplained muscle weakness, hormonal issues, or other concerning symptoms, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Next Steps and Professional Guidance
This summary is based on the best available research as of now. Science may evolve, and new trials could clarify follistatin 344’s role in human health. Before pursuing any unapproved therapy:

  • Speak to a doctor about your specific medical conditions and treatment options.
  • Discuss potential benefits, risks, and alternatives in detail.
  • Report any unexpected symptoms or side effects promptly to a healthcare professional.

Bottom Line
Follistatin 344 shows promise for increasing muscle mass in animals and is under early investigation for rare muscle diseases in humans. However, its use for general fitness or anti-aging is not supported by solid clinical evidence, and safety remains unproven. Always consult a qualified healthcare provider before considering experimental treatments—especially those that could carry serious or life-threatening risks.

(References)

  • * Patel K. Follistatin. Int J Biochem Cell Biol. 1998 Oct;30(10):1087-93. doi: 10.1016/s1357-2725(98)00064-8. PMID: 9785474.

  • * Kubo K, Ikebukuro T, Yata H. Effects of squat training with different depths on lower limb muscle volumes. Eur J Appl Physiol. 2019 Sep;119(9):1933-1942. doi: 10.1007/s00421-019-04181-y. Epub 2019 Jun 22. PMID: 31230110.

  • * Seo MW, Jung SW, Kim SW, Lee JM, Jung HC, Song JK. Effects of 16 Weeks of Resistance Training on Muscle Quality and Muscle Growth Factors in Older Adult Women with Sarcopenia: A Randomized Controlled Trial. Int J Environ Res Public Health. 2021 Jun 23;18(13). doi: 10.3390/ijerph18136762. Epub 2021 Jun 23. PMID: 34201810; PMCID: PMC8267934.

  • * Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension. Circulation. 2023 Jun 13;147(24):1809-1822. doi: 10.1161/CIRCULATIONAHA.122.061501. Epub 2023 Apr 25. PMID: 37096577.

  • * Zhang Y, Dos Santos M, Huang H, Chen K, Iyengar P, Infante R, Polanco PM, Brekken RA, Cai C, Caijgas A, Cano Hernandez K, Xu L, Bassel-Duby R, Liu N, Olson EN. A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution. Cell Rep. 2024 Aug 27;43(8):114587. doi: 10.1016/j.celrep.2024.114587. Epub 2024 Aug 7. PMID: 39116208; PMCID: PMC11472345.

  • * Brown DW, Wee P, Bhandari P, Bukhari A, Grin L, Vega H, Hejazi M, Sosnowski D, Ablack J, Clancy EK, Pink D, Kumar J, Solis Ares MP, Lamb S, Quevedo R, Rawal B, Elian F, Rana N, Morales L, Govindasamy N, Todd B, Delmage A, Gupta S, McMullen N, MacKenzie D, Beatty PH, Garcia H, Parmar M, Gyoba J, McAllister C, Scholz M, Duncan R, Raturi A, Lewis JD. Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles. Cell. 2024 Sep 19;187(19):5357-5375.e24. doi: 10.1016/j.cell.2024.07.023. Epub 2024 Sep 10. PMID: 39260374.

  • * Zhang M, Song Y, Zhu J, Ding P, Chen N. Effectiveness of low-load resistance training with blood flow restriction vs. conventional high-intensity resistance training in older people diagnosed with sarcopenia: a randomized controlled trial. Sci Rep. 2024 Nov 18;14(1):28427. doi: 10.1038/s41598-024-79506-9. Epub 2024 Nov 18. PMID: 39558011; PMCID: PMC11574083.

  • * Xiong Z, Zheng W, Wang H, Gao Y, Wang C. Effects of functional strength training on pain, function, and lower extremity biomechanics in patients with patellofemoral pain syndrome: a randomized clinical trial. J Orthop Surg Res. 2025 Jan 16;20(1):50. doi: 10.1186/s13018-025-05482-z. Epub 2025 Jan 16. PMID: 39825450; PMCID: PMC11740520.

  • * Zhuang M, Gu Y, Wang Z, He X, Chen N. Effects of 12-week whole-body vibration training versus resistance training in older people with sarcopenia. Sci Rep. 2025 Feb 27;15(1):6981. doi: 10.1038/s41598-025-91644-2. Epub 2025 Feb 27. PMID: 40011687; PMCID: PMC11865505.

  • * Bhasin S, Wang C, Chandra MS, Gagliano-Jucá T, Jasuja R. Mechanisms of Testosterone's Anabolic Effects on Muscle and Function: Controversies and New Insights. Endocr Rev. 2026 Mar 11;47(2):280-300. doi: 10.1210/endrev/bnaf041. PMID: 41355050; PMCID: PMC13017102.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.